Search results for "opioids"

showing 10 items of 40 documents

Early palliative care of non‑small cell lung cancer in the context of immunotherapy (Review)

2020

Abstract. The most common cause of mortality due to malig‑ nant neoplasms in the general population around the world is lung cancer. In the last 10 years, there has been an enormous improvement in the treatment of this disease, mainly due to the immunotherapy that activates the immune system to fight cancer. Patients with metastatic non‑small cell lung cancer are a special group of patients requiring not only cancer treatment but also considerable support in the treatment of cancer‑related problems, as well as comorbidities. Early palliative care is important in this area. In addition, there is certain evidence that medicines most commonly administered in palliative care may lower the effic…

lung cancerearly palliative careopioidsimmunotherapyglucorticosteroisOncology Letters
researchProduct

Combined oral prolonged-release oxycodone and naloxone in chronic pain management

2013

Introduction: The use of opioids is associated with unwanted adverse effects, particularly opioid-induced constipation (OIC). The adverse effects of opioids on gastrointestinal function are mediated by the interaction with opioid receptors in the gastrointestinal tract. The most common drugs used for relieving OIC are laxatives, which do not address the opioid receptor-mediated bowel dysfunction and do not provide sufficient relief. Areas covered: This paper discusses the role of a combination of prolongedrelease formulation of oxycodone (OX) and naloxone (N) in the prevention and management of OIC, reporting efficacy and safety outcome of controlled studies. In a therapeutic area of great …

medicine.drug_classSettore MED/41 - Anestesiologiacancer pain chronic pain opioid-antagonist opioids oxycodone--naloxone combinationNaloxonemedicineHumansPharmacology (medical)Adverse effectPharmacologybusiness.industryNaloxoneChronic painGeneral Medicinemedicine.diseaseAnalgesics OpioidDrug CombinationsTreatment OutcomeOpioidAnesthesiaDelayed-Action PreparationsChronic PainGastrointestinal functionbusinessCancer painOxycodoneOpioid antagonistOxycodonemedicine.drug
researchProduct

Combined epidural morphine and bupivacaine in the treatment of lumbosacral radicular neuropathic pain: a noncontrolled prospective study

2016

Simone Vigneri,1,2 Gianfranco Sindaco,2 Marco La Grua,2 Matteo Zanella,2 Laura Ravaioli,2 Valentina Paci,2 Gilberto Pari2 1Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo, Palermo, 2Advanced Algology Research and Pain Medicine Unit, Santa Maria Maddalena Hospital, Occhiobello, RO, Italy Objective: The aim of this study was to investigate the therapeutic effectiveness of epidural morphine and bupivacaine in patients with chronic lumbosacral radicular neuropathic pain after the cessation of treatment.Methods: Twenty-two patients with chronic lumbosacral pain with neuropathic features were enrolled. An indwelling catheter was placed into the epidural sp…

medicine.medical_specialtyChronic painOpioidNeuropathic painEpidural morphine03 medical and health sciences0302 clinical medicine030202 anesthesiologymedicineJournal of Pain ResearchProspective cohort studyBupivacaine; Chronic pain; Epidural; Neuropathic pain; Opioids; Anesthesiology and Pain MedicineOriginal ResearchBupivacainelcsh:R5-920business.industryChronic painopioidsmedicine.diseaseBupivacaineEpidural spaceSurgeryEpidural - Opioids - Bupivacaine - Neuropathic pain - Chronic painAnesthesiology and Pain Medicinemedicine.anatomical_structureAnesthesiaEpiduralNeuropathic painMorphinelcsh:Medicine (General)business030217 neurology & neurosurgeryLumbosacral jointmedicine.drugJournal of Pain Research
researchProduct

Recomendaciones prácticas para el manejo del paciente con dolor crónico durante la pandemia de COVID-19

2021

Resumen La infeccion por SARS-CoV-2 ha evolucionado hasta convertirse progresivamente en una pandemia y en una emergencia de salud publica de importancia internacional que ha obligado a las organizaciones de salud a nivel mundial, regional y local a adoptar una serie de medidas para hacer frente a la COVID-19 e intentar disminuir su impacto, no solo en el ambito social sino tambien en el ambito sanitario, modificandose las pautas de actuacion en los servicios de salud. Dentro de estas recomendaciones, que incluyen las unidades de tratamiento del dolor, los pacientes con sospecha o infeccion confirmada por SARS-CoV-2 pueden encontrase en situacion de espera para consulta medica o tecnicas in…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Critical Care and Intensive Care MedicineArticleHealth servicesHealth personnelSpecial Article03 medical and health sciences0302 clinical medicinePandemicHumansPain ManagementMedicine030212 general & internal medicineOpioidesPandemicsSARS-CoV-2business.industryRisk of infectionPublic healthChronic painManejo del dolorCOVID-19General Medicinemedicine.diseaseDolor crónicoOpioidsAnesthesiology and Pain MedicineEsteroidesSteroidsMedical emergencyChronic PainbusinessHumanities030217 neurology & neurosurgeryRevista Española de Anestesiología y Reanimación
researchProduct

Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world study.

2020

Objective: The objective of this study was to analyze health outcomes, resource utilization, and costs in osteoarthritis patients with chronic nociceptive pain who began treatment with an opioid in real-world practice in Spain. Methods: We designed a non-interventional, retrospective, longitudinal study with 36 months of follow-up using electronic medical records (EMRs) from primary care centers, of patients aged 18+ years who began a new treatment with an opioid drug in usual practice for chronic pain due to osteoarthritis. Health/non-health resource utilization and costs, treatment adherence, pain change, cognitive functioning, and dependence for basic activities of daily living (BADL) we…

medicine.medical_specialtyDiseases of the musculoskeletal systemOsteoarthritisHealth outcomescognitive deficit03 medical and health sciences0302 clinical medicineRheumatologymedicineOrthopedics and Sports MedicineIn patientpain030212 general & internal medicineCognitive deficitOriginal Research030203 arthritis & rheumatologybusiness.industrybasic activities of daily livingChronic painopioidshealthmedicine.diseasenon-health costshealth/non-health costsosteoarthritisNociceptionRC925-935OpioidPhysical therapymedicine.symptombusinessResource utilizationmedicine.drugTherapeutic advances in musculoskeletal disease
researchProduct

US Food and Drug Administration's Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids Pros and Cons, and a European …

2012

Prescriptions for opioid analgesics to manage moderate-to-severe chronic non-cancer pain have increased markedly over the last decade. An unintentional consequence of greater prescription opioid utilization has been the parallel increase in misuse, abuse and overdose, which are serious risks associated with all opioid analgesics. In response to disturbing rises in prescription opioid abuse, the US Food and Drug Administration (FDA) has proposed the implementation of aggressive Risk Evaluation and Mitigation Strategies (REMS). While REMS could dramatically change the development, release, marketing and prescription of extended-release opioids, questions remain on how these programmes may inf…

medicine.medical_specialtyTime FactorsSettore MED/41 - AnestesiologiaLong-Acting Opioids Food and drug administration AnalgesiaRisk AssessmentFood and drug administrationPatient safetyPharmacotherapymedicineHumansPharmacology (medical)Medical prescriptionIntensive care medicineUnited States Food and Drug Administrationbusiness.industryPerspective (graphical)Chronic painLong-Acting Opioids Food and drug administration AnalgesiaOpioid-Related Disordersmedicine.diseaseUnited StatesRisk evaluationAnalgesics OpioidEuropeDelayed-Action PreparationsMedical emergencyChronic PainRisk assessmentbusiness
researchProduct

Brain Opioid Activity and Oxidative Injury: Different Molecular Scenarios Connecting Celiac Disease and Autistic Spectrum Disorder

2020

Celiac Disease (CD) is an immune-mediated disease triggered by the ingestion of wheat gliadin and related prolamins from other cereals, such as barley and rye. Immunity against these cereal-derived proteins is mediated by pro-inflammatory cytokines produced by both innate and adaptive system response in individuals unable to adequately digest them. Peptides generated in this condition are absorbed across the gut barrier, which in these patients is characterized by the deregulation of its permeability. Here, we discuss a possible correlation between CD and Autistic Spectrum Disorder (ASD) pathogenesis. ASD can be induced by an excessive and inappropriate brain opioid activity during the neon…

mitochondrial damageDiseaseReviewNeurotransmissionmedicine.disease_causelcsh:RC321-571Pathogenesis03 medical and health sciences0302 clinical medicineAutistic Spectrum Disordermedicineoxidative stressReceptorlcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biologyEndogenous opioid0303 health sciencesbiologybusiness.industryGeneral Neurosciencefood and beveragesopioidsOpioidImmunologybiology.proteinGliadinbusiness030217 neurology & neurosurgeryOxidative stressceliac diseasemedicine.drugBrain Sciences
researchProduct

Intrauterine and Neonatal Exposure to Opioids: Toxicological, Clinical, and Medico-Legal Issues

2023

Opioids have a rapid transplacental passage (i.e., less than 60 min); furthermore, symptoms characterize the maternal and fetal withdrawal syndrome. Opioid withdrawal significantly impacts the fetus, inducing worse outcomes and a risk of mortality. Moreover, neonatal abstinence syndrome (NAS) follows the delivery, lasts up to 10 weeks, and requires intensive management. Therefore, the prevention and adequate management of NAS are relevant public health issues. This review aims to summarize the most updated evidence in the literature regarding toxicological, clinical, and forensic issues of intrauterine exposure to opioids to provide a multidisciplinary, evidence-based approach for managing …

neonatalopioids.Chemical Health and SafetyexposureHealth Toxicology and Mutagenesisintrauterinemedico-legal issueforensic toxicologyToxicologyToxics
researchProduct

Determinants of Prescription Opioid Use : Population‐Based Evidence from Finland

2021

Background and aims Previous studies have shown that prescription opioid use is more common in the socioeconomically disadvantaged communities in the US. This study examined the area and individual‐level determinants of prescription opioid use in Finland during the period 1995‐2016. Design Logistic regression analysis using nationwide data on filled opioid‐related prescriptions dispensed at Finnish pharmacies and covered by the National Health Insurance. Opioid consumption was linked, using personal identification codes, to population‐based data maintained by Statistics Finland, which records individual background and area‐level characteristics. Setting and participants Working‐age populati…

socioeconomic statusopioiditopioid usepopulation‐basedprescription drugsväestötutkimuslääkemääräyksetprevalenceopioidskäyttöFinlandsosioekonomiset tekijätcodeine
researchProduct

Prescription opioid use and employment : A nationwide Finnish register study

2021

Background: The secular decline in labor market participation and the concurrent increase in opioid use in many developed countries have sparked a policy debate on the possible connection between these two trends. We examined whether the use of prescription opioids was connected to labor market outcomes relating to participation, employment and unemployment among the Finnish population. Methods: The working-age population (aged 19–64 years) living in Finland during the period 1995–2016 was used in the analyses (consisting of 67 903 701 person-year observations). Lagged values of prescription opioid use per capita were used as the exposure. Instrumental variables (IV) estimation method was u…

väestötutkimusENGLANDtyömarkkinatPopulation-basedToxicology3124 Neurology and psychiatryLabor marketVARIABLEStyömarkkina-asemaopioidit0302 clinical medicinePer capitaEconomicsPharmacology (medical)030212 general & internal medicineFinlandmedia_commonAged 80 and overeducation.field_of_studyShort runInstrumental variablePRIMARY-CAREPAINMiddle Aged3. Good healthAnalgesics OpioidPsychiatry and Mental healthPrescriptionsemployment8. Economic growth511 EconomicsDeveloped countryAdultEmploymentprescription drugslääkemääräyksetmedia_common.quotation_subjectPopulationDRUG-USEYoung Adult03 medical and health sciencesHumansMedical prescriptioneducationAgedPharmacologyEstimationPrescription drugstyöllisyysopioidsOpioid-Related Disorderspopulation-based3141 Health care scienceOpioidsSTATESUnemploymentPATTERNSDemographic economicslabor market030217 neurology & neurosurgery
researchProduct